This study reports a significant clinical outcome following the use of bronchoscopic interventional therapy combined with pembrolizumab for treating pulmonary large cell neuroendocrine carcinoma (LCNEC), showcasing a novel approach in managing this aggressive cancer.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11370624 | PMC |
| http://dx.doi.org/10.1111/crj.70009 | DOI Listing |
Publication Analysis
Top Keywords
bronchoscopic interventional
8
interventional therapy
8
therapy combined
8
combined pembrolizumab
8
pulmonary large
8
large cell
8
cell neuroendocrine
8
neuroendocrine carcinoma
8
pembrolizumab treatment
4
treatment pulmonary
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!